Clinical Trials for Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Find clinical trials for non-muscle invasive bladder cancer with carcinoma in situ. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

NCT ID: NCT06545955

This clinical trial is looking at a new treatment called nadofaragene firadenovec for patients with a specific type of bladder cancer known as non-muscle invasive bladder cancer (NMIBC) that hasn't...

Recruiting

Phase: PHASE3 Type: interventional Locations: Myrtle Beach, South Carolina, United States, Fresno, California, United States +9 more

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT ID: NCT04752722

The LEGEND Study is a clinical trial that is investigating a new treatment called EG-70 for patients with a type of bladder cancer known as non-muscle invasive bladder cancer (NMIBC). Specifically,...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Kansas City, Kansas, United States +96 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions